This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Metaproscaline" – news · newspapers · books · scholar · JSTOR (November 2022)

Metaproscaline
Names

IUPAC name 2-(3,4-dimethoxy-5-propoxyphenyl)ethanamine
Identifiers
CAS Number	90132-33-5^Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL161588^Y
ChemSpider	21106345^Y
PubChem CID	44375097
UNII	BE9PTC7J7P^Y
CompTox Dashboard (EPA)	DTXSID10658556
InChI InChI=1S/C13H21NO3/c1-4-7-17-12-9-10(5-6-14)8-11(15-2)13(12)16-3/h8-9H,4-7,14H2,1-3H3^Y Key: LRMHEQAATQTVRI-UHFFFAOYSA-N^Y InChI=1/C13H21NO3/c1-4-7-17-12-9-10(5-6-14)8-11(15-2)13(12)16-3/h8-9H,4-7,14H2,1-3H3 Key: LRMHEQAATQTVRI-UHFFFAOYAS
SMILES COc1c(cc(cc1OCCC)CCN)OC
Properties
Chemical formula	C₁₃H₂₁NO₃
Molar mass	239.311 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Y verify (what is ^YN ?) Infobox references

Metaproscaline, or 3,4-dimethoxy-5-prop oxy phenethylamine, is a lesser-known psychedelic drug. It is an analog of proscaline. Metaproscaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage and the duration are unknown.^[1] Metaproscaline produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of metaproscaline.

See also

References